Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yun Yi Tan"'
Publikováno v:
Journal of Entrepreneurship, Business & Economics; 2024, Vol. 12 Issue 1, p190-230, 41p
Publikováno v:
EDULEARN Proceedings.
Autor:
Claire Glen, Yun Yi Tan, Ashita Waterston, Thomas R. Jeffry Evans, Robert J. Jones, Mark C. Petrie, Ninian N. Lang
Publikováno v:
JACC. CardioOncology. 4(1)
Rapidly accelerated fibrosarcoma B-type (BRAF) and mitogen-activated extracellular signal-regulated kinase (MEK) inhibitors have revolutionized melanoma treatment. Approximately half of patients with melanoma harbor a BRAF gene mutation with subseque
Autor:
Graham MacDonald, Jeff White, David Irvine, Yun Yi Tan, Grant McQuaker, Bahaa Al-Bubseeree, Ashita Waterston, Anne Parker
Publikováno v:
Clinical Genitourinary Cancer. 17:125-131
Purpose To report outcomes from high-dose chemotherapy (HDCT) and autologous stem-cell transplantation (ASCT) for metastatic germ-cell cancer in Scotland. Patients and Methods All patients who underwent this treatment between the years 2001 and 2016
Autor:
Nabilah Abd Raman, Yun Yi Tan
Publikováno v:
Learning Environment and Design ISBN: 9789811581663
The aging society’s population around the world is continuing to increase due to the advance in technology and healthcare. This article outlines an initiative to address the digital inclusion for the Malaysian aging society through an intergenerati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4de38c1f7c9dee790bddb3f5aeb1a9d
https://doi.org/10.1007/978-981-15-8167-0_12
https://doi.org/10.1007/978-981-15-8167-0_12
Publikováno v:
The International journal of neuroscience. 129(12)
Case presentation: A 66-year-old gentleman with metastatic non-small-cell lung cancer developed a wide-based gait following treatment on a clinical trial with cytotoxic chemotherapy and an anti-PD-L1 drug. He had no other significant past medical his
Autor:
Paul A. Cohen, Aime Powell, Steffen Böhm, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Bulsara, Stefanie Avril, Eleanor C. Brockbank, Tjalling Bosse, Gustavo Rubino de Azevedo Focchi, Raji Ganesan, Rosalind M. Glasspool, Brooke E. Howitt, Hyun-Soo Kim, Jung-Yun Lee, Nhu D. Le, Michelle Lockley, Ranjit Manchanda, Trupti Mandalia, W. Glenn McCluggage, Iain McNeish, Divya Midha, Radhika Srinivasan, Yun Yi Tan, Rachael van der Griend, Mayu Yunokawa, Gian F. Zannoni, Naveena Singh, Simi Aggarwal, Holger Bronger, Elizabeth B. Brown, Martin Buck, Syed A. Bukhari, Edwina Coghlan, Nichola Cope, Michelle Samora de Almeida, Cornelius D. De Kroon, Andrew Dean, Michael-John Devlin, Helena M. Ditzel, Enken Drecoll, Takahiro Ebata, Anna Fagotti, Asma Faruqi, Laura Feeney, Kavita Gupta, Ian Harley, Frediano Inzani, Arjun R. Jeyarajah, M.H. Eleanor Koay, Judith R. Kroep, Yee Leung, Alice R. Loft, Daniel MaGee, Sarah McKenna, David Millan, Joanne Millar, Rowan Miller, Ganendra R. Mohan, Sohail Mughal, Asima Mukhopadhyay, Sergio Mancini Nicolau, James Nevin, Abigail S. Oakley, Mary Quigley, Bhavana Rai, Arvind Rajwanshi, Stuart G. Salfinger, Giovanni Scambia, Kate Scatchard, Barbara Schmalfeldt, Bryony Simcock, Priya Singh, Kyle C. Strickland, Vainta Suri, Sheeba Syed, Peter Sykes, Kenji Tamura, Adeline Tan, Jason Tan, Emily Thompson, Anna V. Tinker, Georgia Trevisan, Maria Gabriela Baumgarten Kuster Uyeda, Michelle M. Vaughan, Wilko Weichert, Anthony Williams, Sarah Williams, Hiroshi Yoshida, Pier Carlo Zorzato
Publikováno v:
Cohen, P A, Powell, A, Böhm, S, Gilks, C B, Stewart, C J R, Meniawy, T M, Bulsara, M, Avril, S, Brockbank, E C, Bosse, T, de Azevedo Focchi, G R, Ganesan, R, Glasspool, R M, Howitt, B E, Kim, H S, Lee, J Y, Le, N D, Lockley, M, Manchanda, R, Mandalia, T, McCluggage, W G, McNeish, I, Midha, D, Srinivasan, R, Tan, Y Y, van der Griend, R, Yunokawa, M, Zannoni, G F, The HGSC CRS Collaborative Network (Supplementary 1) & Møgelbjerg Ditzel, H 2019, ' Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma : A systematic review and meta-analysis of individual patient data ', Gynecologic Oncology, vol. 154, no. 2, pp. 441-448 . https://doi.org/10.1016/j.ygyno.2019.04.679
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE
Objective. There is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into complete/near-complete (CRS3), partia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a0a3d918f62859dca88e8d5a6e292c
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf
Autor:
Neil Hawkins, Ruth McLaughlin, Gillian McGaffin, David Creed, Janet Graham, Yun Yi Tan, Graeme Smith, Nicola Williams, Janet Bouttell, Paul Westwood
Publikováno v:
International journal of technology assessment in health care. 35(4)
ObjectivesThe cost-effectiveness of molecular pathology testing is highly context dependent. The field is fast-moving, and national health technology assessment may not be relevant or timely for local decision makers. This study illustrates a method
Publikováno v:
Proceedings of the 2019 5th International Conference on Education and Training Technologies.
e-Warisan SENIBINA is suggested as a one-stop information center for the virtual reality reconstruction of Traditional Malay Muslim Architecture in Peninsular Malaysia to assist documentation and enhance the experience of learning architectural herit